Key Papers
2024 – Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorder
Annals of Clinical and Translational Neurology. 2024, 11(4).
Santoro JD, Khoshnood, MM, Jafarpour S, Nguyen L, Boyd NK, Vogel BN, Kammeyer R, Patel L, Manning MA, Rachubinski AL, Filipink RA, Baumer NT, Santoro SL, Franklin C, Tamrazi B, Yeom KW, Worley G, Espinosa JM, Rafii MS
2023 – What is Down Syndrome Regression Disorder?
Medical Forum. September 2023
Nia Parker
2022 – Assessment and Diagnosis of Down Syndrome Regression Disorder: International Expert Consensus
Frontiers in Neurology. July 2022, 13, 940175.
Santoro JD, Patel L, Kammeyer R, Filipink RA, Gombolay GY, Cardinale KM, Real de Asua D, Zaman S, Santoro SL, Marzouk SM,
Khoshnood M, Vogel BN, Tanna R, Pagarkar D, Dhanani S, Ortega MdC, Partridge R, Stanley MA, Sanders JS, Christy A, Sannar EM, Brown R, McCormick AA, Van Mater H, Franklin C, Worley G, Quinn EA, Capone GT, Chicoine B, Skotko BG
and Rafii MS